Govt panel approves use of Corbevax for 5-12 year age group

Mangaloretoday.com

New Delhi, April 21, 2022: Expert panel of Drug Controller General of India (DCGI)-- India’s drug regulator-- has recommended granting emergency use authorisation for Biological E’s Covid-19 vaccine Corbevax for children in 5 to 12 years age group.

 

Developed by Hyderabad-based firm Biological-E, Corbevax is India’s first indigenously developed RBD protein sub-unit vaccine against Covid-19.

From March 16 this year, Corbevax is being given to children between the ages of 12 and 14 years.

Meanwhile, the government has sought more data from Bharat Biotech before granting approval for use of its Covid-19 vaccine, Covaxin, in children aged 5-12.

Courtesy: India Today